Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.508 SEK | -5.01% | -2.00% | +20.60% |
06-14 | Cantargia AB Reports Further Progress in Ongoing Phase 1 Clinical Trial with CAN10 | CI |
06-11 | Cantargia Appoints New Chief Business Officer | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+20.60% | 83.42M | |
+14.84% | 121B | |
+18.31% | 112B | |
+2.94% | 22.72B | |
-18.26% | 20.82B | |
-18.47% | 16.66B | |
-42.36% | 16.36B | |
-14.23% | 16.19B | |
-0.68% | 13.17B | |
+21.87% | 11.11B |
- Stock Market
- Equities
- CANTA Stock
- News Cantargia AB
- Transcript : Cantargia AB, Q1 2024 Earnings Call, May 21, 2024